Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 2
2010 1
2011 1
2012 2
2014 3
2015 1
2016 6
2017 6
2019 5
2020 6
2021 9
2022 8
2023 6
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

46 results

Results by year

Filters applied: . Clear all
Page 1
Post-treatment LSM rather than change during treatment predicts decompensation in patients with cACLD after HCV cure.
Semmler G, Alonso López S, Pons M, Lens S, Dajti E, Griemsmann M, Zanetto A, Burghart L, Hametner-Schreil S, Hartl L, Manzano M, Rodriguez-Tajes S, Zanaga P, Schwarz M, Luisa Gutierrez M, Jachs M, Pocurull A, Polo B, Ecker D, Mateos B, Izquierdo S, Real Y, Ahumada A, Josef Maria Bauer D, Benjamin Mauz J, Casanova-Cabral M, Gschwantler M, Paolo Russo F, Azzaroli F, Maasoumy B, Reiberger T, Forns X, Genesca J, Bañares R, Mandorfer M; cACLD-SVR Study Group (in alphabetical order). Semmler G, et al. Among authors: pons m. J Hepatol. 2024 Mar 21:S0168-8278(24)00198-3. doi: 10.1016/j.jhep.2024.03.015. Online ahead of print. J Hepatol. 2024. PMID: 38521170 Free article.
Alpha-1 Antitrypsin Augmentation and the Liver Phenotype of Adults With Alpha-1 Antitrypsin Deficiency (Genotype Pi∗ZZ).
Fromme M, Hamesch K, Schneider CV, Mandorfer M, Pons M, Thorhauge KH, Pereira V, Sperl J, Frankova S, Reichert MC, Benini F, Burbaum B, Kleinjans M, Amzou S, Rademacher L, Bewersdorf L, Verbeek J, Nevens F, Genesca J, Miravitlles M, Nuñez A, Schaefer B, Zoller H, Janciauskiene S, Waern J, Oliveira A, Maia L, Simões C, Mahadeva R, Fraughen DD, Trauner M, Krag A, Lammert F, Bals R, Gaisa NT, Aigner E, Griffiths WJ, Denk H, Teumer A, McElvaney NG, Turner AM, Trautwein C, Strnad P. Fromme M, et al. Among authors: pons m. Clin Gastroenterol Hepatol. 2024 Feb;22(2):283-294.e5. doi: 10.1016/j.cgh.2023.08.038. Epub 2023 Sep 15. Clin Gastroenterol Hepatol. 2024. PMID: 37716616
Point-of-Care Noninvasive Prediction of Liver-Related Events in Patients With Nonalcoholic Fatty Liver Disease.
Pons M, Rivera-Esteban J, Ma MM, Davyduke T, Delamarre A, Hermabessière P, Dupuy J, Wong GL, Yip TC, Pennisi G, Tulone A, Cammà C, Petta S, de Lédinghen V, Wong VW, Augustin S, Pericàs JM, Abraldes JG, Genescà J. Pons M, et al. Clin Gastroenterol Hepatol. 2023 Aug 11:S1542-3565(23)00626-2. doi: 10.1016/j.cgh.2023.08.004. Online ahead of print. Clin Gastroenterol Hepatol. 2023. PMID: 37573987
Pediatric and Adult Liver Disease in Alpha-1 Antitrypsin Deficiency.
Ruiz M, Lacaille F, Schrader C, Pons M, Socha P, Krag A, Sturm E, Bouchecareilh M, Strnad P. Ruiz M, et al. Among authors: pons m. Semin Liver Dis. 2023 Aug;43(3):258-266. doi: 10.1055/a-2122-7674. Epub 2023 Jul 4. Semin Liver Dis. 2023. PMID: 37402396 Review.
New variants of alpha-1-antitrypsin: structural simulations and clinical expression.
Gonzalez A, Belmonte I, Nuñez A, Farago G, Barrecheguren M, Pons M, Orriols G, Gabriel-Medina P, Rodríguez-Frías F, Miravitlles M, Esquinas C. Gonzalez A, et al. Among authors: pons m. Respir Res. 2022 Dec 10;23(1):339. doi: 10.1186/s12931-022-02271-8. Respir Res. 2022. PMID: 36496391 Free PMC article.
Prediction of clinical events by liver stiffness and chronic kidney disease by NAFLD in patients with type-2 diabetes.
Rivera-Esteban J, Pons M, Planas A, Manzano-Nuñez R, Hernández C, Simó-Servat O, Bañeras J, Soler MJ, Seron D, Boixadera A, Augustin S, Simó R, Ferreira-González I, Genescà J, Pericàs JM; PRECISED consortium. Rivera-Esteban J, et al. Among authors: pons m. Gastroenterol Hepatol. 2023 Nov;46(9):682-691. doi: 10.1016/j.gastrohep.2022.11.001. Epub 2022 Nov 23. Gastroenterol Hepatol. 2023. PMID: 36435379 English, Spanish.
Risk of infections in patients with NAFLD and Type 2 Diabetes under treatment with SGLT2 inhibitors and relationship with liver outcomes: A retrospective case-control study.
Bañares J, Manzano-Nuñez R, Prió A, Rivera-Esteban J, Camps-Relats L, Villarejo A, Ruiz-Ortega L, Pons M, Ciudin A, Salcedo MT, Vargas V, Genescà J, Pericàs JM. Bañares J, et al. Among authors: pons m. Front Endocrinol (Lausanne). 2022 Aug 24;13:945626. doi: 10.3389/fendo.2022.945626. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 36093073 Free PMC article.
46 results